{"id":927126,"date":"2026-01-13T19:01:52","date_gmt":"2026-01-14T00:01:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/"},"modified":"2026-01-13T19:01:52","modified_gmt":"2026-01-14T00:01:52","slug":"tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/","title":{"rendered":"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm"},"content":{"rendered":"
\n

SAN DIEGO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP<\/strong><\/a> is investigating potential violations of U.S. federal securities laws involving Travere Therapeutics, Inc. (NASDAQ: TVTX).<\/p>\n

\n If you have information that could assist in the Travere investigation or if you are a Travere investor who suffered a loss and would like to learn more, you can provide your information here:<\/strong>\n <\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/cases-travere-therapeutics-inc-investigation-tvtx.html<\/strong>
\n <\/a>\n <\/p>\n

\n You can also contact attorney <\/strong>
\n
\n J.C. Sanchez<\/strong>
\n <\/a>
\n of Robbins Geller by calling 800\/449-4900 or via e-mail at <\/strong>
\n
\n info@rgrdlaw.com<\/strong>
\n <\/a>
\n .<\/strong>\n <\/p>\n

\n THE COMPANY: <\/strong>Travere is a biopharmaceutical company that develops therapies for people living with rare kidney and metabolic diseases in the United States.<\/p>\n

\n THE INVESTIGATION: <\/strong>Robbins Geller is investigating whether Travere and certain of its top executives made materially false and\/or misleading statements and\/or omitted material information regarding Travere\u2019s business and operations.<\/p>\n

\n ABOUT ROBBINS GELLER<\/strong>: Robbins Geller Rudman & Dowd LLP is one of the world\u2019s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases \u2013 more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs\u2019 firms in the world, and the Firm\u2019s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever \u2013 $7.2 billion \u2013 in In re Enron Corp. Sec. Litig.<\/em> Please visit the following page for more information:<\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/services-litigation-securities-fraud.html<\/strong>
\n <\/a>\n <\/p>\n

Past results do not guarantee future outcomes.\u00a0
Services may be performed by attorneys in any of our offices.\u00a0<\/p>\n

Contact:
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Robbins Geller Rudman & Dowd LLP
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0J.C. Sanchez
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0655 W. Broadway, Suite 1900, San Diego, CA 92101
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0800-449-4900
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0info@rgrdlaw.com<\/strong><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Travere Therapeutics, Inc. (NASDAQ: TVTX). If you have information that could assist in the Travere investigation or if you are a Travere investor who suffered a loss and would like to learn more, you can provide your information here: https:\/\/www.rgrdlaw.com\/cases-travere-therapeutics-inc-investigation-tvtx.html You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800\/449-4900 or via e-mail at info@rgrdlaw.com . THE COMPANY: Travere is a biopharmaceutical company that develops therapies for people living with rare kidney and metabolic diseases in the United States. THE INVESTIGATION: Robbins Geller is investigating whether Travere and certain of its top executives … <\/p>\n

Continue reading “TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-927126","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Travere Therapeutics, Inc. (NASDAQ: TVTX). If you have information that could assist in the Travere investigation or if you are a Travere investor who suffered a loss and would like to learn more, you can provide your information here: https:\/\/www.rgrdlaw.com\/cases-travere-therapeutics-inc-investigation-tvtx.html You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800\/449-4900 or via e-mail at info@rgrdlaw.com . THE COMPANY: Travere is a biopharmaceutical company that develops therapies for people living with rare kidney and metabolic diseases in the United States. THE INVESTIGATION: Robbins Geller is investigating whether Travere and certain of its top executives … Continue reading "TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-14T00:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm\",\"datePublished\":\"2026-01-14T00:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/\"},\"wordCount\":340,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/\",\"name\":\"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=\",\"datePublished\":\"2026-01-14T00:01:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - Market Newsdesk","og_description":"SAN DIEGO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Travere Therapeutics, Inc. (NASDAQ: TVTX). If you have information that could assist in the Travere investigation or if you are a Travere investor who suffered a loss and would like to learn more, you can provide your information here: https:\/\/www.rgrdlaw.com\/cases-travere-therapeutics-inc-investigation-tvtx.html You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800\/449-4900 or via e-mail at info@rgrdlaw.com . THE COMPANY: Travere is a biopharmaceutical company that develops therapies for people living with rare kidney and metabolic diseases in the United States. THE INVESTIGATION: Robbins Geller is investigating whether Travere and certain of its top executives … Continue reading \"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-14T00:01:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm","datePublished":"2026-01-14T00:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/"},"wordCount":340,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/","name":"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=","datePublished":"2026-01-14T00:01:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNTMyNSM3MzYwMjc0IzIxMzY1Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvtx-alert-investigation-launched-into-travere-therapeutics-inc-rgrd-law-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/927126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=927126"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/927126\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=927126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=927126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=927126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}